Aditx Therapeutics (ADTX)
(Delayed Data from NSDQ)
$2.53 USD
+0.16 (6.75%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $2.43 -0.10 (-3.95%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Balance Sheet
Fiscal Year End for Aditxt Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 0 | 3 | 8 | 11 | 0 |
Receivables | 6 | 1 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 1 | 0 | 0 |
Inventories | 1 | 1 | 0 | 0 | 0 |
Other Current Assets | 0 | 1 | 0 | 0 | 0 |
Total Current Assets | 7 | 5 | 9 | 11 | 0 |
Net Property & Equipment | 2 | 2 | 2 | 1 | 0 |
Investments & Advances | 22 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 11 | 0 | 1 | 0 | 0 |
Total Assets | 45 | 11 | 17 | 13 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 16 | 0 | 0 | 0 | 0 |
Accounts Payable | 9 | 2 | 2 | 0 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 1 | 1 | 1 | 0 |
Total Current Liabilities | 26 | 4 | 4 | 1 | 3 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 29 | 6 | 6 | 2 | 3 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 144 | 100 | 78 | 32 | 9 |
Retained Earnings | -128 | -95 | -67 | -21 | -12 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 16 | 5 | 10 | 11 | -3 |
Total Liabilities & Shareholder's Equity | 45 | 11 | 17 | 13 | 0 |
Total Common Equity | 16 | 5 | 10 | 11 | -3 |
Shares Outstanding | 0.20 | 0.10 | 0.00 | NA | NA |
Book Value Per Share | 80.25 | 52.10 | 10.18 | 0.00 | 0.00 |
Fiscal Year End for Aditxt Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 0 | 2 | 0 | 0 |
Receivables | NA | 6 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1 | 1 | 1 | 1 |
Other Current Assets | NA | 0 | 1 | 1 | 1 |
Total Current Assets | NA | 7 | 3 | 2 | 2 |
Net Property & Equipment | NA | 2 | 2 | 2 | 2 |
Investments & Advances | NA | 22 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 11 | 0 | 0 | 0 |
Total Assets | NA | 45 | 8 | 7 | 8 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 16 | 4 | 3 | 1 |
Accounts Payable | NA | 9 | 4 | 5 | 3 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 2 | 0 | 0 |
Total Current Liabilities | NA | 26 | 11 | 10 | 6 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 29 | 12 | 11 | 8 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 144 | 113 | 103 | 101 |
Retained Earnings | NA | -128 | -117 | -107 | -101 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 16 | -4 | -4 | 0 |
Total Liabilities & Shareholder's Equity | NA | 45 | 8 | 7 | 8 |
Total Common Equity | 0 | 16 | -4 | -4 | 0 |
Shares Outstanding | 0.20 | 0.20 | 0.20 | 0.10 | 0.10 |
Book Value Per Share | 0.00 | 80.25 | -21.10 | -38.70 | 0.70 |